Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

216 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Glutathione-S Transferase in Psoriasis and Associated Comorbidities and the Effect of Dimethyl Fumarate in This Pathway.
Campione E, Mazzilli S, Di Prete M, Dattola A, Cosio T, Lettieri Barbato D, Costanza G, Lanna C, Manfreda V, Gaeta Schumak R, Prignano F, Coniglione F, Ciprani F, Aquilano K, Bianchi L. Campione E, et al. Among authors: prignano f. Front Med (Lausanne). 2022 Feb 8;9:760852. doi: 10.3389/fmed.2022.760852. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35211489 Free PMC article. Review.
Psoriasis and its management in women of childbearing age: tools to increase awareness in dermatologists and patients.
De Simone C, Calabrese L, Balato A, Cannavò SP, Dattola A, Esposito M, Fargnoli MC, Giuffrida R, Hansel K, Musumeci ML, Napolitano M, Offidani A, Parodi A, Patrizi A, Peris K, Radi G, Venturini M, Prignano F; SIDeMaST "Psoriasis in Women of Childbearing Age" Task Force. De Simone C, et al. Among authors: prignano f. G Ital Dermatol Venereol. 2020 Aug;155(4):434-440. doi: 10.23736/S0392-0488.20.06748-6. G Ital Dermatol Venereol. 2020. PMID: 33050681 Free article.
Guselkumab: an anti-IL-23 antibody for the treatment of moderate-to-severe plaque psoriasis.
Chiricozzi A, Costanzo A, Fargnoli MC, Malagoli P, Piaserico S, Amerio P, Argenziano G, Balato N, Bardazzi F, Bianchi L, Carrera CG, Conti A, Dapavo P, De Simone C, Loconsole F, Lo Schiavo A, Malara G, Musumeci ML, Parodi A, Peris K, Prignano F, Rongioletti F, Talamonti M, Potenza C. Chiricozzi A, et al. Among authors: prignano f. Eur J Dermatol. 2021 Feb 1;31(1):3-16. doi: 10.1684/ejd.2021.3965. Eur J Dermatol. 2021. PMID: 33648915 Review.
Patient satisfaction with calcipotriol/betamethasone dipropionate cutaneous foam for the treatment of plaque psoriasis: The LION real-life multicenter prospective observational cohort study.
Campanati A, Atzori L, Potenza C, Damiani G, Bianchi L, Corazza M, Tiberio R, Prignano F, Argenziano G, Fargnoli MC, Stingeni L, Mazzotta A, De Pità O, Mazzatenta C, Feliciani C, Donini M, Offidani A, Peris K; LION study group. Campanati A, et al. Among authors: prignano f. Dermatol Ther. 2021 Sep;34(5):e15077. doi: 10.1111/dth.15077. Epub 2021 Aug 9. Dermatol Ther. 2021. PMID: 34333823 Free PMC article.
Risk of infections in psoriasis: assessment and challenges in daily management.
De Simone C, Fargnoli MC, Amerio P, Bianchi L, Esposito M, Pirro F, Potenza C, Ricceri F, Rongioletti F, Stingeni L, Prignano F. De Simone C, et al. Among authors: prignano f. Expert Rev Clin Immunol. 2021 Nov;17(11):1211-1220. doi: 10.1080/1744666X.2021.1997592. Epub 2021 Nov 1. Expert Rev Clin Immunol. 2021. PMID: 34696673 Review.
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study.
Galluzzo M, Talamonti M, Atzori L, Bardazzi F, Campanati A, Di Cesare A, Diotallevi F, Flori ML, Mugheddu C, Offidani A, Piaserico S, Russo F, Sacchelli L, Bianchi L, Prignano F. Galluzzo M, et al. Among authors: prignano f. Expert Opin Biol Ther. 2022 Apr;22(4):547-554. doi: 10.1080/14712598.2022.2029841. Epub 2022 Jan 20. Expert Opin Biol Ther. 2022. PMID: 35043741
Sharing Patient and Clinician Experiences of Moderate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon Patient Wellbeing.
Prignano F, Brunasso AMG, Fabbrocini G, Argenziano G, Bardazzi F, Borroni RG, Burlando M, Cagni AE, Campione E, Cinotti E, Cuccia A, Dastoli S, De Pasquale R, De Simone C, Di Lernia V, Dini V, Fargnoli MC, Faure E, Giacchetti A, Giofrè C, Girolomoni G, Lasagni C, Lembo S, Loconsole F, Montesu MA, Pella P, Pigatto P, Richetta AG, Stroppiana E, Venturini M, Zichichi L, Piaserico S. Prignano F, et al. J Clin Med. 2022 May 16;11(10):2801. doi: 10.3390/jcm11102801. J Clin Med. 2022. PMID: 35628929 Free PMC article.
Brodalumab for the Treatment of Moderate-to-Severe Psoriasis: An Expert Delphi Consensus Statement.
Fargnoli MC, Bardazzi F, Bianchi L, Dapavo P, Fabbrocini G, Gisondi P, Micali G, Offidani AM, Pellacani G, Skroza N, Angileri RG, Burlando M, Campanati A, Carrera CG, Chiricozzi A, Conti A, Simone C, Di Lernia V, Errichetti E, Galluzzo M, Guarneri C, Lasagni C, Lembo S, Loconsole F, Megna M, Musumeci ML, Prignano F, Richetta AG, Trovato E, Venturini M, Peris K, Pinton PC. Fargnoli MC, et al. Among authors: prignano f. J Clin Med. 2023 May 18;12(10):3545. doi: 10.3390/jcm12103545. J Clin Med. 2023. PMID: 37240650 Free PMC article.
216 results